PDL BIOPHARMA, INC. Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PDL BIOPHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PDL BIOPHARMA, INC. for December 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.74 | 20,000 | 54,800 | 1,387 | 21.4 K to 1.4 K (-93.51 %) |
Dec 29 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.69 | 268,600 | 722,534 | 17,458,060 | 17.2 M to 17.5 M (+1.56 %) |
Dec 29 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.70 | 235,000 | 634,500 | 17,189,460 | 17 M to 17.2 M (+1.39 %) |
Dec 29 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.65 | 128,000 | 339,200 | 16,954,460 | 16.8 M to 17 M (+0.76 %) |
Dec 23 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.60 | 485,000 | 1,261,000 | 16,826,460 | 16.3 M to 16.8 M (+2.97 %) |
Dec 23 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.59 | 850,000 | 2,201,500 | 16,341,460 | 15.5 M to 16.3 M (+5.49 %) |
Dec 23 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.63 | 230,000 | 604,900 | 15,491,460 | 15.3 M to 15.5 M (+1.51 %) |
Dec 22 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Sell | S | 2.61 | 277,934 | 724,574 | 200,000 | 477.9 K to 200 K (-58.15 %) |
Dec 22 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Sell | S | 2.62 | 50,000 | 131,200 | 477,934 | 527.9 K to 477.9 K (-9.47 %) |
Dec 18 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.61 | 398,000 | 1,038,780 | 15,261,460 | 14.9 M to 15.3 M (+2.68 %) |
Dec 18 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.58 | 1,350,000 | 3,483,000 | 14,863,460 | 13.5 M to 14.9 M (+9.99 %) |
Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | S | 2.56 | 200,000 | 512,000 | 405,559 | 605.6 K to 405.6 K (-33.03 %) |
Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | Monnet Dominique | President and CEO | Sell | S | 2.60 | 500,000 | 1,300,000 | 734,921 | 1.2 M to 734.9 K (-40.49 %) |
Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | S | 2.56 | 200,000 | 512,000 | 405,559 | 605.6 K to 405.6 K (-33.03 %) |
Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | Monnet Dominique | President and CEO | Sell | S | 2.60 | 500,000 | 1,300,000 | 734,921 | 1.2 M to 734.9 K (-40.49 %) |
Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.68 | 75,000 | 201,000 | 21,387 | 96.4 K to 21.4 K (-77.81 %) |
Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.68 | 75,000 | 201,000 | 21,387 | 96.4 K to 21.4 K (-77.81 %) |
Dec 15 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.59 | 1,000,000 | 2,590,000 | 13,513,460 | 12.5 M to 13.5 M (+7.99 %) |
Dec 15 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.62 | 640,000 | 1,676,800 | 12,513,460 | 11.9 M to 12.5 M (+5.39 %) |
Dec 15 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.45 | 450,000 | 1,102,500 | 11,873,460 | 11.4 M to 11.9 M (+3.94 %) |
Dec 04 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | D | 0.00 | 11,544 | 0 | 605,559 | 617.1 K to 605.6 K (-1.87 %) |
Dec 04 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.52 | 75,000 | 189,000 | 30,337 | 105.3 K to 30.3 K (-71.20 %) |
Dec 04 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | D | 0.00 | 11,544 | 0 | 605,559 | 617.1 K to 605.6 K (-1.87 %) |
Dec 04 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.52 | 75,000 | 189,000 | 30,337 | 105.3 K to 30.3 K (-71.20 %) |